Murray JL - Search Results

1

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

Rivera E, Valero V, Syrewicz L, Rahman Z, Esteva FJ, Theriault RL, Rosales MM, Booser D, Murray JL, Bast RC Jr, Hortobagyi GN. Rivera E, et al. Among authors: murray jl. J Clin Oncol. 2001 Mar 15;19(6):1716-22. doi: 10.1200/JCO.2001.19.6.1716. J Clin Oncol. 2001. PMID: 11251001 Clinical Trial.

2

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

Ibrahim NK, Rahman Z, Valero V, Murray JL 3rd, Frye D, Hortobagyi GN. Ibrahim NK, et al. Among authors: murray jl 3rd. Cancer Invest. 2002;20(1):29-37. doi: 10.1081/cnv-120000363. Cancer Invest. 2002. PMID: 11852999 Clinical Trial.

3

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

Esteva FJ, Valero V, Booser D, Guerra LT, Murray JL, Pusztai L, Cristofanilli M, Arun B, Esmaeli B, Fritsche HA, Sneige N, Smith TL, Hortobagyi GN. Esteva FJ, et al. Among authors: murray jl. J Clin Oncol. 2002 Apr 1;20(7):1800-8. doi: 10.1200/JCO.2002.07.058. J Clin Oncol. 2002. PMID: 11919237 Clinical Trial.

4

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: murray jl. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

5

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. Trent JC, et al. Among authors: murray jl. Clin Cancer Res. 2003 Jul;9(7):2426-34. Clin Cancer Res. 2003. PMID: 12855614 Clinical Trial.

6

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

Pusztai L, Zhen JH, Arun B, Rivera E, Whitehead C, Thompson WJ, Nealy KM, Gibbs A, Symmans WF, Esteva FJ, Booser D, Murray JL, Valero V, Smith TL, Hortobagyi GN. Pusztai L, et al. Among authors: murray jl. J Clin Oncol. 2003 Sep 15;21(18):3454-61. doi: 10.1200/JCO.2003.02.114. J Clin Oncol. 2003. PMID: 12972520 Clinical Trial.

7

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.

Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. Moulder S, et al. Among authors: murray jl. Cancer. 2012 May 1;118(9):2378-84. doi: 10.1002/cncr.26571. Epub 2011 Oct 17. Cancer. 2012. PMID: 22006179 Free PMC article. Clinical Trial.

8

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.

Esteva FJ, Moulder SL, Gonzalez-Angulo AM, Ensor J, Murray JL, Green MC, Koenig KB, Lee MH, Hortobagyi GN, Yeung SC. Esteva FJ, et al. Among authors: murray jl. Cancer Chemother Pharmacol. 2013 Jan;71(1):63-72. doi: 10.1007/s00280-012-1977-9. Epub 2012 Sep 28. Cancer Chemother Pharmacol. 2013. PMID: 23053261 Free PMC article. Clinical Trial.

9

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer.

Murthy RK, Varma A, Mishra P, Hess KR, Young E, Murray JL, Koenig KH, Moulder SL, Melhem-Bertrandt A, Giordano SH, Booser D, Valero V, Hortobagyi GN, Esteva FJ. Murthy RK, et al. Among authors: murray jl. Cancer. 2014 Jul 1;120(13):1932-8. doi: 10.1002/cncr.28689. Epub 2014 Mar 26. Cancer. 2014. PMID: 24677057 Free article.

10

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Among authors: murray jl 3rd. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters